These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12469144)

  • 1. Differential expression patterns of hyaluronan receptors CD44 and RHAMM in transitional cell carcinomas of urinary bladder.
    Kong QY; Liu J; Chen XY; Wang XW; Sun Y; Li H
    Oncol Rep; 2003; 10(1):51-5. PubMed ID: 12469144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
    Li H; Guo L; Li JW; Liu N; Qi R; Liu J
    Int J Oncol; 2000 Nov; 17(5):927-32. PubMed ID: 11029494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive loss of CD44 gene expression in invasive bladder cancer.
    Sugino T; Gorham H; Yoshida K; Bolodeoku J; Nargund V; Cranston D; Goodison S; Tarin D
    Am J Pathol; 1996 Sep; 149(3):873-82. PubMed ID: 8780391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer.
    Boorjian S; Ugras S; Mongan NP; Gudas LJ; You X; Tickoo SK; Scherr DS
    Urology; 2004 Aug; 64(2):383-8. PubMed ID: 15302512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.
    Gómez-Román JJ; Saenz P; Molina M; Cuevas González J; Escuredo K; Santa Cruz S; Junquera C; Simón L; Martínez A; Gutiérrez Baños JL; López-Brea M; Esparza C; Val-Bernal JF
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):459-65. PubMed ID: 15701828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient receptor potential vanilloid type 1 (TRPV1) expression changes from normal urothelium to transitional cell carcinoma of human bladder.
    Lazzeri M; Vannucchi MG; Spinelli M; Bizzoco E; Beneforti P; Turini D; Faussone-Pellegrini MS
    Eur Urol; 2005 Oct; 48(4):691-8. PubMed ID: 15992990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
    Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
    BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancerous and precancerous changes in the tumor margin areas of patients with bladder cancers].
    Blume B; Theuring F
    Z Urol Nephrol; 1985 Feb; 78(2):71-6. PubMed ID: 3993243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns.
    Miyake H; Hara I; Kamidono S; Eto H
    J Urol; 2004 Sep; 172(3):1127-9. PubMed ID: 15311055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of CD44 variant isoforms by cell lines and tissue specimens of transitional cell carcinomas.
    Chuang CK; Liao SK
    Anticancer Res; 2003; 23(6C):4635-9. PubMed ID: 14981907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bladder cancer in Sri Lanka: experience from a tertiary referral center.
    Goonewardena SA; De Silva WA; De Silva MV
    Int J Urol; 2004 Nov; 11(11):969-72. PubMed ID: 15509199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia.
    Desai S; Lim SD; Jimenez RE; Chun T; Keane TE; McKenney JK; Zavala-Pompa A; Cohen C; Young RH; Amin MB
    Mod Pathol; 2000 Dec; 13(12):1315-23. PubMed ID: 11144928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases in human transitional cell carcinoma of the urinary bladder.
    Sumi T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Hattori K; Sugimura K; Kawashima H; Nakatani T; Ishiko O
    Oncol Rep; 2003; 10(2):345-9. PubMed ID: 12579270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.